rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert J. Palmisano

Director

Company insider

Files Form 4 as: Director and 10% owner, AEON Biopharma; Director, RxSight; President and CEO, Wright Medical Group; Director, Avedro; President and CEO, Wright Medical Group; Director, Osteotech; President and CEO, ev3; Director, Abbott Medical Optics.

Every Form 4 they filed

In numbers

Trades disclosed
145
Buys
1
Sells
0
Bought
$998K
Sold
$0
Companies
9
Companies where not an officer
5
First trade
28 Apr 2006
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
Wright Medical GroupDirector, Officer · last 11 Nov 20201 buy · 0 sells
Wright Medical GroupDirector, Officer · last 1 Oct 20150 buys · 0 sells
ev3Director, Officer · last 12 Jul 20100 buys · 0 sells
IntralaseDirector, Officer · last 2 Apr 20070 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AEON AEON BiopharmaDirector, 10% owner · Biotechnology · last 17 Jun 20260 buys · 0 sells
RXST RxSightDirector · Medical Devices · last 17 Jun 20260 buys · 0 sells
AvedroDirector · last 21 Nov 20190 buys · 0 sells
OsteotechDirector · last 16 Nov 20100 buys · 0 sells
Abbott Medical OpticsDirector · last 26 Feb 20090 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—222,684 at $0.00filing
17 Jun 2026filed 22 Jun 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—222,684 at $0.00filing
17 Jun 2026filed 18 Jun 2026RXST RxSightMedical DevicesSEC FORM 4 Code A—37,037filing
17 Jun 2026filed 18 Jun 2026RXST RxSightMedical DevicesSEC FORM 4 Code A—37,037filing
3 Jun 2025filed 4 Jun 2025RXST RxSightMedical DevicesSEC FORM 4 Code A—10,752filing
21 May 2025filed 23 May 2025AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—308,641 at $0.00filing
31 Aug 2024filed 10 Sep 2024AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—36,021 at $0.00filing
31 Aug 2024filed 4 Sep 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—96,210 at $0.00filing
31 Aug 2024filed 4 Sep 2024AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—36,021 at $0.00filing
6 Jun 2024filed 10 Jun 2024RXST RxSightMedical DevicesSEC FORM 4 Code A—2,554filing
19 Mar 2024filed 21 Mar 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—16,260 at $0.00filing
14 Aug 2023filed 16 Aug 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—58,851 at $0.00filing
1 Jun 2023filed 5 Jun 2023RXST RxSightMedical DevicesSEC FORM 4 Code A—5,731 at $0.00filing
2 Jun 2022filed 3 Jun 2022RXST RxSightMedical DevicesSEC FORM 4 Code A—8,624 at $0.00filing
3 Aug 2021filed 5 Aug 2021RXST RxSightMedical DevicesSEC FORM 4 Code A—5,733 at $0.00filing
3 Aug 2021filed 5 Aug 2021RXST RxSightMedical DevicesSEC FORM 4 Code A—7,645 at $0.00filing
11 Nov 2020filed 13 Nov 2020Wright Medical Groupoption or derivativeSEC FORM 4 Code D—181,429filing
11 Nov 2020filed 13 Nov 2020Wright Medical Groupoption or derivativeSEC FORM 4 Code D—149,008filing
11 Nov 2020filed 13 Nov 2020Wright Medical Groupoption or derivativeSEC FORM 4 Code D—137,373filing
11 Nov 2020filed 13 Nov 2020Wright Medical Groupoption or derivativeSEC FORM 4 Code D—271,076filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.